Target intelligence / Profile preview

Bacterial outer membrane component (OM)

Target
OM
Molecular classification
Bacterial structural component, Membrane protein, Transporter, Enzyme, Other
01

Overview

The bacterial outer membrane (OM) is a specialized asymmetric lipid bilayer found exclusively in Gram-negative bacteria, serving as a critical permeability barrier that protects the cell from toxic environmental agents and antibiotics (1.1.2, 1.2.3). It consists of an inner leaflet of phospholipids and an outer leaflet primarily composed of lipopolysaccharide (LPS), which acts as a potent endotoxin and is essential for bacterial viability (1.2.1, 1.3.4). Embedded within this membrane are various outer membrane proteins (OMPs), including porins for nutrient transport and complex machinery like the β-barrel assembly machine (BAM) and the lipopolysaccharide transport (Lpt) system, which are responsible for membrane biogenesis (1.1.3, 1.3.1). In clinical settings, the OM is a major driver of antimicrobial resistance by restricting drug entry and housing multidrug efflux pumps (1.3.4, 1.4.4). Therapeutic targeting of OM components includes direct disruption by polymyxins or the inhibition of specific assembly proteins by novel agents like darobactin and murepavadin (1.3.1, 1.3.5). Because these components are unique to bacteria and absent in eukaryotic cells, they represent highly selective targets for the development of next-generation antibiotics (1.4.2, 1.4.3).

Other names
Gram-negative outer membraneBacterial envelope componentsBacterial cell envelopeOuter membrane (OM)Bacterial cell wall components
02

Mechanism of action

Direct disruption of the lipid bilayer, inhibition of lipopolysaccharide transport (LptD inhibition), inhibition of outer membrane protein assembly (BamA inhibition), inhibition of lipid A biosynthesis (LpxC inhibition), and competitive displacement of divalent cations (1.3.4, 1.3.5, 1.4.4).

03

Biological functions

Permeability barrierNutrient uptakeCell wall assemblyEndotoxin activityAdhesionVirulenceEfflux of toxic compounds
04

Disease associations

Bacterial infectionSepsisSeptic shockAntimicrobial resistance (AMR)
05

Safety considerations

NephrotoxicityNeurotoxicityJarisch-Herxheimer reaction (due to rapid LPS release)Rapid development of resistance through porin loss or LPS modificationPoor selectivity for specific bacterial species
06

Interacting drugs

Polymyxin B

6 more in the full profile.

07

Biomarkers

Lipopolysaccharide (LPS) levelsProcalcitonin (PCT)C-reactive protein (CRP)Bacterial load (CFU/mL)Outer membrane vesicle (OMV) concentration

Beyond the preview

Go deeper on Bacterial outer membrane component (OM).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bacterial outer membrane component (OM).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call